Cargando…

Matrix abnormalities in pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease, marked by excessive scarring, which leads to increased tissue stiffness, loss in lung function and ultimately death. IPF is characterised by progressive fibroblast and myofibroblast proliferation, and extensive deposition of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Upagupta, Chandak, Shimbori, Chiko, Alsilmi, Rahmah, Kolb, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2018
Materias:	Lung Science Conference
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489108/ https://www.ncbi.nlm.nih.gov/pubmed/29950306 http://dx.doi.org/10.1183/16000617.0033-2018

Ejemplares similares

Fibrocytes in pulmonary fibrosis: a brief synopsis
por: Maharaj, Shyam, et al.
Publicado: (2013)

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2019)

What have we learned from basic science studies on idiopathic pulmonary fibrosis?
por: Yanagihara, Toyoshi, et al.
Publicado: (2019)

How bacteria hack the matrix and dodge the bullets of immunity
por: Paulsson, Magnus, et al.
Publicado: (2018)

The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
por: Hussell, Tracy, et al.
Publicado: (2018)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

Immune checkpoints in chronic obstructive pulmonary disease
por: Wilkinson, Tom M.A.
Publicado: (2017)

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives
por: Chelladurai, Prakash, et al.
Publicado: (2016)

The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease
por: Patel, Dhiren F., et al.
Publicado: (2018)

Chronic lung diseases: entangled in extracellular matrix
por: Burgess, Janette K., et al.
Publicado: (2022)

The Prevalence of Pulmonary Embolism in Patients With Interstitial Lung Disease: A Cross-Sectional Retrospective Study
por: Alsilmi, Rahmah
Publicado: (2022)

Therapeutic strategies in pneumonia: going beyond antibiotics
por: Müller-Redetzky, Holger, et al.
Publicado: (2015)

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
por: Kolb, Martin, et al.
Publicado: (2017)

Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
por: Kreuter, Michael, et al.
Publicado: (2017)

Acellular human lung scaffolds to model lung disease and tissue regeneration
por: Gilpin, Sarah E., et al.
Publicado: (2018)

Intersections of lung progenitor cells, lung disease and lung cancer
por: Kim, Carla F.
Publicado: (2017)

Cell therapy for lung disease
por: Geiger, Sabine, et al.
Publicado: (2017)

Shared epithelial pathways to lung repair and disease
por: Spella, Magda, et al.
Publicado: (2017)

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)

Macrophage adaptation in airway inflammatory resolution
por: Kaur, Manminder, et al.
Publicado: (2015)

The heterogeneity of lung macrophages in the susceptibility to disease
por: Morales-Nebreda, Luisa, et al.
Publicado: (2015)

The exposome concept: a challenge and a potential driver for environmental health research
por: Siroux, Valérie, et al.
Publicado: (2016)

Natural experiments and large databases in respiratory and cardiovascular disease
por: Vestbo, Jørgen
Publicado: (2016)

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
por: Zheng, Xiang, et al.
Publicado: (2020)

The ageing lung under stress
por: Korfei, Martina, et al.
Publicado: (2020)

Endoplasmic reticulum stress in lung disease
por: Marciniak, Stefan J.
Publicado: (2017)

Mitochondrial dysfunction in lung ageing and disease
por: Cloonan, Suzanne M., et al.
Publicado: (2020)

Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)

Respiratory muscle senescence in ageing and chronic lung diseases
por: Gea, Joaquim, et al.
Publicado: (2020)

PULSE-DOSE STEROIDS FOR USE IN PULMONARY FIBROSIS RELATED TO COVID-19 INFECTION
por: BRADY, JAMES, et al.
Publicado: (2021)

Lung Transplantation for Pulmonary Fibrosis Associated With Hermansky-Pudlak Syndrome. A Single-center Experience
por: Benvenuto, Luke, et al.
Publicado: (2022)

Good Things Come in 2s: Type 2 Alveolar Epithelial Cells and Fibroblast Growth Factor Receptor 2
por: Shimbori, Chiko, et al.
Publicado: (2020)

Combined pulmonary fibrosis and emphysema: effect of pulmonary rehabilitation in comparison with chronic obstructive pulmonary disease
por: Tomioka, Hiromi, et al.
Publicado: (2016)

Idiopathic pulmonary fibrosis: A guide for nurse practitioners
por: Vega-Olivo, Michelle, et al.
Publicado: (2018)

Clinical use of nintedanib in patients with idiopathic pulmonary fibrosis
por: Hajari Case, Amy, et al.
Publicado: (2017)

Metabolic heterogeneity of idiopathic pulmonary fibrosis: a metabolomic study
por: Zhao, Yidan D, et al.
Publicado: (2017)

Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
por: Snyder, Laurie D, et al.
Publicado: (2020)

Quantification of pulmonary perfusion in idiopathic pulmonary fibrosis with first pass dynamic contrast-enhanced perfusion MRI
por: Weatherley, Nicholas D, et al.
Publicado: (2021)

PREDICTORS OF POST-COVID-19 PULMONARY FIBROSIS: A CASE SERIES
por: CÎRJALIU, R.-E., et al.
Publicado: (2022)

Neutrophil lymphocyte ratio as an indicator for disease progression in Idiopathic Pulmonary Fibrosis
por: Achaiah, Andrew, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_erotaabfc95g4tpljnleumob3d